MedPath

Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial

Phase 2
Completed
Conditions
Panic Disorder
Interventions
Behavioral: Physical exercise
Behavioral: Cognitive-behavioral therapy
Registration Number
NCT01076777
Lead Sponsor
University of Bergen
Brief Summary

The purpose of this study is to compare manualised physical exercise conducted in groups to manualised cognitive-behavioral therapy conducted in groups as treatment for panic disorder with or without agoraphobia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Written informed consent obtained
  • Clinical diagnosis of panic disorder with and without agoraphobia according to The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR, 4th ed., text revision; American Psychiatric Association, 2000), established through administration of Structural Clinical Interview for DSM-IV axis I disorders (SCID I; First, Spitzer, Gibbon, & Williams, 1995).
Exclusion Criteria
  • Brain-organic disorders according to DSM-IV-TR
  • The presence of psychotic disorders according to DSM-IV-TR, established through administration of SCID I
  • Present substance-abuse
  • Medical condition that excludes participation in physical activity
  • Major Depressive Disorder according to DSM-IV-TR established through administration of SCID I.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical exercisePhysical exerciseManualised Exercise performed in groups (5-8 participants per group). 3 sessions (á 60 minutes) per week for 12 consecutive weeks
Cognitive-behavioral therapyCognitive-behavioral therapyCognitive-behavioral therapy conducted in groups (5-8 participants per group). 1 session (á 2-2.25 hours depending on group size) per week for 12 consecutive weeks
Primary Outcome Measures
NameTimeMethod
Mobility Inventory (MI) - Alone & AccompaniedBaseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Agoraphobic Cognitions Questionnaire (ACQ)Baseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Body Sensations QuestionnaireBaseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Panic frequency - Self-report & Clinician-ratingBaseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Panic distress/disability - Self-report & Clinician-ratingBaseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Secondary Outcome Measures
NameTimeMethod
Beck Anxiety Inventory (BAI)Baseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
State-Trait Anxiety Inventory - State & Trait (STAI S/T)Baseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Beck Depression Inventory II (BDI-II)Baseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up
Quality of Life Inventory (QoLI)Baseline; Pre-treatment; Post-treatment; 6-months follow-up; 12-monthts follow-up

Trial Locations

Locations (1)

Solli Hospital

🇳🇴

Bergen, Nesttun, Norway

© Copyright 2025. All Rights Reserved by MedPath